FDA Approves First Generic of Once-Daily GLP-1 Injection to …
FDA approved the first generic referencing Victoza (liraglutide injection) 18 mg/3 mL, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults...
Generic GLP-1 drug: FDA approves version of liraglutide ... - NBC News
Dec 23, 2024 · The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
FDA Approves First Generic Version of Victoza for Type 2 Diabetes
1 day ago · US Food and Drug Administration. FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes. December 23, 2024. ... Hikma receives FDA approval and launches the generic version of Victoza ®, Liraglutide, in the US. News release. Hikma Pharmaceuticals. December 26, 2024.
FDA Approves First Generic of Once-Daily GLP-1 Injection to …
Dec 23, 2024 · Liraglutide injection and certain other GLP-1 medications are currently in shortage. The FDA prioritizes assessment of generic drug applications for drugs in shortage to help improve patient...
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment - U.S. News ...
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...
FDA Approves First Generic of GLP-1 Receptor Agonist Victoza ...
December 23, 2024 -- Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct ...
FDA approves generic GLP-1 drug, a daily injection, for people …
Dec 23, 2024 · The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for...
FDA Approves First Generic of Once-Daily GLP-1 Injection to …
Dec 23, 2024 · Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor...
FDA approves first generic liraglutide once-daily injection
Dec 27, 2024 · The U.S. Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to...
FDA Approves Generic GLP-1 Medicine, Liraglutide, (a Victoza …
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes.